Data base for:

  • Conferences
  • Research funding opportunities
  • Competitions / Awards

Register for free and add any data by yourself!

Filter conferences

 
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
 
      
      
 
      
 
      
      
      
      
      
      
      
      
      
      
2nd Annual Chronic Kidney Disease Drug Development Summit

2nd Annual Chronic Kidney Disease Drug Development Summit

Categories

Date of beginning

Monday, 06 May 2019

Duration

3 days

City

Boston

Country

United States

Contact

Georgina FitzGerald

E-Mail

This email address is being protected from spambots. You need JavaScript enabled to view it.

Memo

The 2nd Chronic Kidney Disease Drug Development (CKD3) focuses exclusively on overcoming challenges limiting the development of more efficacious and disease-modifying drugs against diabetic nephropathy, genetic and glomerular kidney disease. Incorporating insights from 25+ industry leading speakers, this uniquely specific forum assesses key clinical and translational hurdles and the hottest emerging research necessary to achieve the potential of next-generation CKD drugs. Join 80+ of your colleagues to accelerate the development of SGLT-2 inhibitors, antagonists of renal fibrosis and more, and advance the clinical validity and commercial viability for next-generation standards of care. URLs:  Tickets: https://go.evvnt.com/355870-0?pid=5569  Brochure: https://go.evvnt.com/355870-2?pid=5569  Price Conference + 2 Workshops: USD 4097.0 Conference + 1 Workshop: USD 3498.0 Conference Only: USD 2899.0 Workshop Only: USD 699.0 Artists / Speakers: George Bakris, University of Chicago, Vlado Perkovic, The George Institute Australia, Matthias Kretzler, University of Michigan, Jyothis George, Boehringer Ingelheim, Pernille B. Laerkegaard Hansen, AstraZeneca, Matthew Breyer, Janssen Research & Development, Lori Gowen Morton, Regeneron Pharmaceuticals, Curtis Rambaran, Daiichi Sankyo, Fabio Dorigotti, Vifor Pharma, Radko Komers, Retrophin, Colin Meyer, Reata Pharmaceuticals, Carol Moreno Quinn, AstraZeneca, Bergur Stefansson, AstraZeneca, Barbara Gillespie, University of North Carolina, Melissa West, American Society of Nephrology, Anna Greka, Brigham and Women’s Hospital, John Brennan, AbbVie, Gigi Shafai, Akebia Therapeutics, Rahul Kakkar, Corvidia Therapeutics, Harry Alcorn, Diamedica, Dario Lemos, Brigham and Women's Hospital, Steven Coca, Mount Sinai, Darren Kelly, Certa Therapeutics, Guangping Gao, University of Massachusetts Medical School, Benjamin Freedman, University of Washington, Nichole Jefferson, KHI Patient Family Partnership Council, Tim Johnson, UCB, Lesley Inker, Tufts University School of Medicine Monday May 06, 2019 at 8:00 am (ends Wednesday May 08, 2019 at 5:00 pm) Venue details Revere Hotel Boston Common 200 Stuart Street, Boston 02116, United States